During the last session, Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s traded shares were 20.86 million, with the beta value of the company hitting 0.93. At the end of the trading day, the stock’s price was $0.29, reflecting an intraday gain of 7.64% or $0.02. The 52-week high for the VRPX share is $5.48, that puts it down -1789.66 from that peak though still a striking 20.69% gain since the share price plummeted to a 52-week low of $0.23. The company’s market capitalization is $5.30M, and the average intraday trading volume over the past 10 days was 0.3 million shares, and the average trade volume was 3.89 million shares over the past three months.

Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information

Virpax Pharmaceuticals Inc (VRPX) registered a 7.64% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.64% in intraday trading to $0.29, hitting a weekly high. The stock’s 5-day price performance is 6.25%, and it has moved by -17.22% in 30 days. Based on these gigs, the overall price performance for the year is -91.96%. The short interest in Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is 0.35 million shares and it means that shorts have 1.04 day(s) to cover.

The consensus price target of analysts on Wall Street is $3, which implies an increase of 90.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $3 respectively. As a result, VRPX is trading at a discount of -934.48% off the target high and -934.48% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -20.69%.

VRPX Dividends

Virpax Pharmaceuticals Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Virpax Pharmaceuticals Inc (VRPX) shares are Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund . Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 25.31 shares. This amounts to just over 0.17 percent of the company’s overall shares, with a $7311.0 market value. The same data shows that the other fund manager holds slightly less at 8.76, or about 0.06% of the stock, which is worth about $2529.0.